Showing results (521-530 of 654) with videos related to

Sort By:
Pageof 66
Kidney International|May 22, 2026
Distinct proteomic signatures of urinary extracellular vesicles link to albuminuria and treatment responses in diabetic kidney diseaseMartijn H van Heugten, Sebastian B Beckmann, Madonna Salib, et al.
Lancet (London, England)|December 18, 2023
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trialKatherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, et al.
JAMA Cardiology|June 3, 2026
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical TrialsKevin Bryan Lo, John W Ostrominski, Yasuhiro Hamatani, et al.
JACC. Heart Failure|August 27, 2021
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart FailureJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2021
Effects of Dapagliflozin in Stage 4 Chronic Kidney DiseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.
European Heart Journal|April 1, 2021
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trialHiddo J L Heerspink, C David Sjöström, Niels Jongs, et al.
Journal of the American Society of Nephrology : JASN|April 2, 2026
Association of Urinary Epidermal Growth Factor with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 InhibitionErik Moedt, Akihiko Koshino, Niels Jongs, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Diabetes Care|June 29, 2021
Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD TrialFrederik Persson, Peter Rossing, Priya Vart, et al.
BMJ Open Diabetes Research & Care|April 11, 2024
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetesViktor Rotbain Curovic, Brede A Sørland, Tine W Hansen, et al.
Pageof 66